0
0
0
Increasing Transparency in Generic Drug Applications Act
12/15/2023, 4:06 PM
Current Status of Bill S 775
Bill S 775 is currently in the status of Bill Introduced since March 14, 2023. Bill S 775 was introduced during Congress 118 and was introduced to the Senate on March 14, 2023. Bill S 775's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 14, 2023
Bipartisan Support of Bill S 775
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 775
Primary Policy Focus
HealthComments
Sponsors and Cosponsors of S 775
Latest Bills
Transparency in Reporting of Adversarial Contributions to Education Act
Bill HR 1049December 6, 2025
National Defense Authorization Act for Fiscal Year 2026
Bill S 2296December 6, 2025
Wildfire Risk Evaluation Act
Bill HR 3924December 6, 2025
HOMEFRONT Act of 2025
Bill HR 5095December 6, 2025
Enhancing Administrative Reviews for Broadband Deployment Act
Bill HR 5419December 6, 2025
PROTECT Our Kids Act
Bill HR 1069December 6, 2025
A resolution recognizing the 250th anniversary of the United States Marine Corps.
Bill SRES 124December 6, 2025
Claiming Age Clarity Act
Bill HR 5284December 6, 2025
Medal of Honor Act
Bill HR 695December 6, 2025
SUPPORT for Patients and Communities Reauthorization Act of 2025
Bill HR 2483December 6, 2025
Expanding Access to Low-Cost Generics Act of 2023
Bill S 1114February 6, 2024
Lower Costs, More Transparency Act
Bill HR 5378February 6, 2024
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Bill HR 3839February 5, 2024